CN1984642A - 包含TG227ea或TG134a作为推进剂的气溶胶悬浮制剂 - Google Patents

包含TG227ea或TG134a作为推进剂的气溶胶悬浮制剂 Download PDF

Info

Publication number
CN1984642A
CN1984642A CNA2005800238201A CN200580023820A CN1984642A CN 1984642 A CN1984642 A CN 1984642A CN A2005800238201 A CNA2005800238201 A CN A2005800238201A CN 200580023820 A CN200580023820 A CN 200580023820A CN 1984642 A CN1984642 A CN 1984642A
Authority
CN
China
Prior art keywords
acid
propellant gas
aerosol suspension
suspension thing
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800238201A
Other languages
English (en)
Chinese (zh)
Inventor
克里斯特尔·施梅尔策
阿恩·弗罗姆德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of CN1984642A publication Critical patent/CN1984642A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2005800238201A 2004-07-02 2005-06-25 包含TG227ea或TG134a作为推进剂的气溶胶悬浮制剂 Pending CN1984642A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
DE102004032322.4 2004-07-02
DE102005023334.1 2005-05-17

Publications (1)

Publication Number Publication Date
CN1984642A true CN1984642A (zh) 2007-06-20

Family

ID=35612719

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800238201A Pending CN1984642A (zh) 2004-07-02 2005-06-25 包含TG227ea或TG134a作为推进剂的气溶胶悬浮制剂

Country Status (4)

Country Link
CN (1) CN1984642A (uk)
DE (1) DE102004032322A1 (uk)
UA (1) UA89789C2 (uk)
ZA (1) ZA200609718B (uk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1809243T5 (pl) 2004-07-02 2022-12-27 Boehringer Ingelheim International Gmbh Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Also Published As

Publication number Publication date
DE102004032322A1 (de) 2006-02-09
ZA200609718B (en) 2008-08-27
UA89789C2 (uk) 2010-03-10

Similar Documents

Publication Publication Date Title
KR101297061B1 (ko) 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형
TW200800294A (en) Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant
CN108495680A (zh) 由上锁功能和计数器组成的吸入喷雾器
CA2226934C (en) Ipratropium bromide enantiomer with a prolonged duration of action
US20070041911A1 (en) Hfc solution formulations containing salbutamol hydrochloride or salbutamol citrate
EP2007349B1 (de) Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
CN101410189A (zh) 用以施用药物制剂的剂量喷雾器
CN1984642A (zh) 包含TG227ea或TG134a作为推进剂的气溶胶悬浮制剂
CA2578449C (en) Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants
CN101355937A (zh) 噻托铵盐在治疗中度持续性哮喘中的用途
CN101384248A (zh) 用于具有二种或多种活性剂以及至少一种表面活性剂的气雾剂的药物制剂
DE102006009599A1 (de) Treibgasabsorbtion bei Dosieraerosolen mit Verpackungen
DE102005023334A1 (de) Aeorosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
MX2008009323A (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1104972

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20070620

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1104972

Country of ref document: HK